VEGFA and deep vein thrombosis: The specificity of the insult to the glomerular endothelial cells has also been observed in kidney biopsy samples from patients experiencing nephrotoxicity after anti-VEGF therapy: most of these patients developed renal thrombotic microangiopathy (TMA), characterized by glomerular endothelial cell swelling and focal glomerular capillary thrombosis [8].